CirChem AB Cash Flow-to-Debt Ratio
CirChem AB cash flow-to-debt ratio. CirChem AB (CIRCHE) has a Cash Flow-to-Debt Ratio of -0.21x as of June 2026, meaning its operating cash flow of Skr-5.45 Million could theoretically repay 0% of its total liabilities (Skr26.15 Million) in one year. Check CirChem AB cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of CirChem AB (2017–2025)
Cash flow-to-debt ratio of CirChem AB from 2017 to 2025. Historical debt coverage capacity for CirChem AB across 9 annual periods. Check total reinvestment intensity of CirChem AB to assess the company's total reinvestment commitment from operating cash flow.
CirChem AB Cash Flow-to-Debt Ratio by Year (2017–2025)
CirChem AB cash flow-to-debt ratio by year from 2017 to 2025. Year-by-year debt coverage analysis for CirChem AB. For the full cash flow conversion analysis, see cash flow conversion of CirChem AB.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.55x | Skr-13.70 Million | Skr25.14 Million | ▼ -32.4% |
| 2024 | -0.41x | Skr-6.38 Million | Skr15.49 Million | ▲ +63.0% |
| 2023 | -1.11x | Skr-26.68 Million | Skr24.00 Million | ▼ -30.2% |
| 2022 | -0.85x | Skr-21.49 Million | Skr25.17 Million | ▼ -692.0% |
| 2021 | -0.11x | Skr-2.78 Million | Skr25.77 Million | ▼ -159.2% |
| 2020 | 0.18x | Skr2.27 Million | Skr12.47 Million | ▲ +116.3% |
| 2019 | -1.12x | Skr-13.55 Million | Skr12.11 Million | ▼ -4987.2% |
| 2018 | 0.02x | Skr307.60K | Skr13.43 Million | ▼ -74.4% |
| 2017 | 0.09x | Skr307.60K | Skr3.44 Million | — |